Lugano, Switzerland (May 6th, 2024) – Privilège Ventures announced today the appointment of Angelica Morrone as its newest General Partner. Angelica will play a pivotal role in shaping the strategic direction of the firm and furthering its mission to support innovative startups and entrepreneurs and to create value for investors.

Angelica Morrone brings a wealth of expertise to her new role, having held key positions in both investment and operational capacities. Her proven track record of identifying promising opportunities and nurturing them to success aligns seamlessly with Privilège Ventures’ mission to support visionary entrepreneurs.

“I am truly delighted about Angelica joining our firm” said Jacqueline Ruedin Rüsch, Privilège Ventures Founding General Partner. “Having had the privilege of witnessing her professional acumen and personal integrity over the past few years, I have no doubt that our company will greatly benefit from her skills. Her addition further strengthens our team and reinforces our commitment to driving impactful investments and returns for our investors.”

Angelica’s appointment comes at a pivotal time for Privilège Ventures as it continues to expand its portfolio and strengthen its position in the venture capital landscape. Her extensive experience and strategic insights will be invaluable assets as the firm pursues new opportunities and endeavors to make a lasting impact on the startup ecosystem.

“I am thrilled to be joining Privilège Ventures as a General Partner,” said Angelica Morrone. “The firm’s dedication to supporting entrepreneurs and fostering innovation resonates deeply with me, and I am excited to contribute to its continued success. I am looking forward to playing a key role in driving the growth of both the company and its funds.”

For more information or to arrange an interview contact:
Greta Lazzarini

About Privilège Ventures
Privilège Ventures is a Swiss-based Venture Capital firm, authorized by the Swiss Financial Market Supervisory Authority (FINMA). The company, based in Lugano, invests in seed stage startups across Europe mainly in DeepTech and MedTech.

You can download our Press Release in PDF and share it